NexImmune Inc.

0.00
-0.14 (-100.00%)
At close: Mar 03, 2025, 9:30 AM
0.10
100000.00%
Pre-market: Jan 10, 2025, 09:30 AM EST

NexImmune Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue 1.02M 1.5M 870.28K 618.99K 436.37K 204.65K
Gross Profit -1.02M -1.5M -870.28K -618.99K -436.37K -204.65K
Operating Income -29.19M -63.08M -53.26M -27.85M -20.89M -13.24M
Interest Income 698.39M 664.37K 52.51K 20.84K 246.78K 272.44K
Pretax Income -32.34M -62.51M -50.9M -29.87M -20.55M -12.83M
Net Income -32.34M 514.18M -51.75M -31.64M -20.3M -12.83M
Selling & General & Admin 9.91M 15.93M 15.8M 10.01M 5.71M 5.24M
Research & Development 18.26M 47.15M 37.46M 17.84M 15.17M 8M
Other Expenses n/a -87.68K -61.41K 89.78K 92.28K 136.79K
Operating Expenses 28.17M 63.08M 53.26M 27.85M 20.89M 13.24M
Interest Expense n/a n/a 905.33K 1.68M n/a n/a
Selling & Marketing Expenses -12.99B n/a n/a n/a n/a n/a
Cost & Expenses 29.19M 63.08M 53.26M 27.85M 20.89M 13.24M
Income Tax -2 -576.69M 843.92K 1.77M -246.78K 409.22K
Shares Outstanding (Basic) 1.05M 962.36K 913.16K 910.31K 900.86K 900.86K
Shares Outstanding (Diluted) 1.05M 962.36K 913.16K 910.31K 900.86K 900.86K
EPS (Basic) -30.82 534.29 -56.67 -34.76 -22.53 -14.25
EPS (Diluted) -30.82 534.29 -56.67 -34.76 -22.53 -14.25
EBITDA -28.17M -61.59M -52.39M -27.12M -20.45M -13.04M
Depreciation & Amortization 1.02M 1.5M 870.28K 618.99K 436.37K 204.65K